Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133361) titled 'Clinical evaluation and strategy optimization of antiviral therapy for pregnant women with high HBV viral load in Ningxia: a multicenter real-world cohort study' on Sept. 24.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Peking University First Hospital Ningxia Women and Children's Hospital (Ningxia Hui Autonomous Region Maternal and Child Health Hospital)
Condition:
pregnant women with high HBV viral load
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: High Viral Load Treatment Group:400;
Countries of Recruitment:
C...